Reliability of hypothalamic–pituitary–adrenal axis assessment methods for use in population-based studies

Population-based studies have been hampered in exploring hypothalamic–pituitary–adrenal axis (HPA) activity as a potential explanatory link between stress-related and metabolic disorders due to their lack of incorporation of reliable measures of chronic cortisol exposure. The purpose of this review is to summarize current literature on the reliability of HPA axis measures and to discuss the feasibility of performing them in population-based studies. We identified articles through PubMed using search terms related to cortisol, HPA axis, adrenal imaging, and reliability. The diurnal salivary cortisol curve (generated from multiple salivary samples from awakening to midnight) and 11 p.m. salivary cortisol had the highest between-visit reliabilities (r = 0.63–0.84 and 0.78, respectively). The cortisol awakening response and dexamethasone-suppressed cortisol had the next highest between-visit reliabilities (r = 0.33–0.67 and 0.42–0.66, respectively). Based on our own data, the inter-reader reliability (rs) of adrenal gland volume from non-contrast CT was 0.67–0.71 for the left and 0.47–0.70 for the right adrenal glands. While a single 8 a.m. salivary cortisol is one of the easiest measures to perform, it had the lowest between-visit reliability (R = 0.18–0.47). Based on the current literature, use of sampling multiple salivary cortisol measures across the diurnal curve (with awakening cortisol), dexamethasone-suppressed cortisol, and adrenal gland volume are measures of HPA axis tone with similar between-visit reliabilities which likely reflect chronic cortisol burden and are feasible to perform in population-based studies.

[1]  A M Hansen,et al.  Long‐term stability of salivary cortisol , 2005, Scandinavian journal of clinical and laboratory investigation.

[2]  E. Cadenas,et al.  Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain , 2007 .

[3]  I. Chiodini,et al.  The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. , 2009, European journal of endocrinology.

[4]  R. Rubin,et al.  Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. , 1995, Archives of general psychiatry.

[5]  R. Spielmann,et al.  Limitations of Intraoperative Adrenal Remnant Volume Measurement in Patients Undergoing Subtotal Adrenalectomy , 2008, World Journal of Surgery.

[6]  M. Szklo,et al.  Epidemiology: Beyond the Basics , 1999 .

[7]  X. Bertagna,et al.  Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology. , 1994, British journal of clinical pharmacology.

[8]  J. Amsterdam,et al.  Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: A pilot study , 1987, Psychiatry Research.

[9]  F. Holsboer,et al.  Pharmacological and Nonpharmacological Factors Influencing Hypothalamic–Pituitary–Adrenocortical Axis Reactivity in Acutely Depressed Psychiatric In-patients, Measured by the Dex-CRH Test , 2003, Neuropsychopharmacology.

[10]  I. Heuser,et al.  The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. , 1994, Journal of psychiatric research.

[11]  K. Watson,et al.  Association of Salivary Cortisol Circadian Pattern With Cynical Hostility: Multi-Ethnic Study of Atherosclerosis , 2009, Psychosomatic medicine.

[12]  Carol M. Worthman,et al.  Estimating between- and within-individual variation in cortisol levels using multilevel models , 2005, Psychoneuroendocrinology.

[13]  Kazue Takano,et al.  Adrenocortical hyperplasia associated with ACTH-dependent Cushing's syndrome: comparison of the size of adrenal glands with clinical and endocrinological data. , 2004, Endocrine journal.

[14]  M. Roizen,et al.  Examining a Bidirectional Association Between Depressive Symptoms and Diabetes , 2009 .

[15]  H. Kraemer,et al.  Design decisions to optimize reliability of daytime cortisol slopes in an older population. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[16]  M. Cooper,et al.  Diagnosis and Treatment of ACTH Deficiency , 2005, Reviews in Endocrine and Metabolic Disorders.

[17]  S. Cleary,et al.  Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. , 2000, The British journal of psychiatry : the journal of mental science.

[18]  W. Gozansky,et al.  Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic–pituitary–adrenal axis activity , 2005, Clinical endocrinology.

[19]  B. Carroll,et al.  Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. , 1983, Archives of general psychiatry.

[20]  F. Pouwer,et al.  Depression and Type 2 Diabetes Over the Lifespan: A Meta-Analysis , 2009, Diabetes Care.

[21]  K. Horton,et al.  Adrenal gland volume and dexamethasone-suppressed cortisol correlate with total daily salivary cortisol in African-American women. , 2007, The Journal of clinical endocrinology and metabolism.

[22]  C. Kirschbaum,et al.  The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. , 1999, Life sciences.

[23]  G. Chrousos,et al.  Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss. , 1993, The Journal of clinical endocrinology and metabolism.

[24]  H. Raff.  Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. , 2009, The Journal of clinical endocrinology and metabolism.

[25]  Sam R. Miller,et al.  A pilot study to assess the feasibility of measurement of adrenal gland volume by magnetic resonance imaging , 2010, Acta radiologica.

[26]  R. Feldman,et al.  Measuring cortisol in human psychobiological studies , 2007, Physiology & Behavior.

[27]  D. Mikhailidis,et al.  Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. , 2009, The Journal of clinical endocrinology and metabolism.

[28]  P. Björntorp,et al.  Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. , 1996, Obesity research.

[29]  M. Kosteljanetz,et al.  Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test , 2005, Clinical endocrinology.

[30]  D. Granger,et al.  Medication effects on salivary cortisol: Tactics and strategy to minimize impact in behavioral and developmental science , 2009, Psychoneuroendocrinology.

[31]  B. McEwen,et al.  Allostatic load biomarkers of chronic stress and impact on health and cognition , 2010, Neuroscience & Biobehavioral Reviews.

[32]  S. Golden,et al.  Pre-Analytic Considerations for the Proper Assessment of Hormones of the Hypothalamic-Pituitary Axis in Epidemiological Research , 2006, European Journal of Epidemiology.

[33]  S. Golden.  A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. , 2007, Current diabetes reviews.

[34]  C. Kirschbaum,et al.  The relationship between smoking status and cortisol secretion. , 2007, Journal of Clinical Endocrinology and Metabolism.

[35]  C. Bhagat.  Diagnosis and Complications of Cushing's Syndrome: a Consensus Statement. , 2004 .

[36]  T. Beblo,et al.  Stability of the dexamethasone suppression test in borderline personality disorder with and without comorbid PTSD: a one-year follow-up study. , 2007, Journal of clinical psychology.

[37]  F. Hucklebridge,et al.  Exploration of the awakening cortisol response in relation to diurnal cortisol secretory activity. , 2001, Life sciences.

[38]  S Rosberg,et al.  Circadian cortisol rhythms in healthy boys and girls: relationship with age, growth, body composition, and pubertal development. , 1997, The Journal of clinical endocrinology and metabolism.

[39]  R. Rubin,et al.  Adrenal gland volume in major depression: Relationship to basal and stimulated pituitary-adrenal cortical axis function , 1996, Biological Psychiatry.

[40]  B. Kudielka,et al.  Salivary cortisol as a biomarker in stress research , 2009, Psychoneuroendocrinology.

[41]  C. Kirschbaum,et al.  Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. , 1997, Life sciences.

[42]  R. Walker,et al.  Comparisons of plasma and salivary cortisol determinations for the diagnostic efficacy of the dexamethasone suppression test , 1990, Biological Psychiatry.

[43]  Reynolds,et al.  Reproducibility of the low dose dexamethasone suppression test: comparison between direct plasma and salivary cortisol assays , 1998, Clinical endocrinology.

[44]  M. Rauh,et al.  Influence of commercial collection devices for saliva on the reliability of salivary steroids analysis , 2006, Steroids.

[45]  F. Holsboer,et al.  Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. , 1982, Journal of affective disorders.

[46]  D. Grobbee,et al.  Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. , 1998, The Journal of clinical endocrinology and metabolism.

[47]  B. Kudielka,et al.  Salivary cortisol sampling compliance: comparison of patients and healthy volunteers , 2004, Psychoneuroendocrinology.

[48]  J. Puder,et al.  Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. , 2005, The Journal of clinical endocrinology and metabolism.

[49]  R. Rugulies.  Depression as a predictor for coronary heart disease. a review and meta-analysis. , 2002, American journal of preventive medicine.